Omnibrx Biotechnologies Private Limited

Omnibrx Biotechnologies Private Limited - life sciences in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U29306GJ2016PTC092297 Incorporated 02 June 2016 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company life sciences MSME · Small
Revenue · FY 2025
₹9.31 Cr
▲ 24% YoY
Net loss · FY 2025
₹11.13 Cr
Net margin -119.5%
EBITDA · FY 2025
-₹9.5 Cr
EBITDA margin -102%
Authorised capital
₹8 Lakh
Registered with MCA
Paid-up capital
₹2.38 Lakh
Issued & subscribed
Open charges
₹1.13 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
23
Provident fund records

About Omnibrx Biotechnologies Private Limited

Data last updated:

Omnibrx Biotechnologies Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 02 June 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U29306GJ2016PTC092297. Its GSTIN is 24AACCO3300N1ZO (Gujarat).

The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹2.38 Lakh. It is led by directors Ravindra Dhirubhai Patel (Managing Director) and Heenaben Ravindrakumar Patel.

Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 Block A Times Corporate Park, Ahmedabad, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.31 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹11.13 Cr (net margin -119.5%) and EBITDA of -₹9.5 Cr (EBITDA margin -102%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 54% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: OmniBRx Biotechnologies. As per MCA filings, the company has open charges of ₹1.13 Cr on record. The company has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.

Omnibrx Biotechnologies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0087940). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omnibrx.com.

Company details

CIN U29306GJ2016PTC092297
Registration Number 092297
Incorporation Date 02 June 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0087940

Recognitions & Rankings of Omnibrx Biotechnologies

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0087940

Contact details

Omnibrx Biotechnologies Private Limited's registered office is in Ahmedabad, Gujarat. Its website is omnibrx.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Corporate House No. 5 Block A Times Corporate Park, Opp. Cooper Stone Thalej – Shilaj Road, Ahmedabad, Gujarat, India – 380059
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Omnibrx Biotechnologies Private Limited, buy the company report.

Comprehensive company report
Omnibrx Biotechnologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Omnibrx Biotechnologies operates one associated brand: OmniBRx Biotechnologies. Each brand links to its own profile.

BrandDescriptionWebsite
Single-use bioreactors are manufactured for vaccine and cell therapy production.omnibrx.com

Business activity

The main business activity of Omnibrx Biotechnologies is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC10Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment

To see the full business activity and turnover split of Omnibrx Biotechnologies Private Limited, buy the company report.

Financials of Omnibrx Biotechnologies Private Limited

FY 2024 filings available

Omnibrx Biotechnologies Private Limited reported revenue of ₹9.31 Cr (up 24% YoY) for FY 2025.

Revenue · FY 2025
₹9.31 Cr ▲ 24%
Net loss · FY 2025
₹11.13 Cr margin -119.5%
EBITDA · FY 2025
-₹9.5 Cr margin -102%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▼ 21%
5 years · compounded
▲ 54%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 50%
5 years · compounded
▼ 91%

Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 24% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹9.5 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.13 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-102%
Net Profit Margin-119.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Omnibrx Biotechnologies Private Limited, buy the company report.

Board of directors of Omnibrx Biotechnologies Private Limited

Omnibrx Biotechnologies has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Heenaben Ravindrakumar PatelDirector27 Sep 201610 Years 1 MonthsCurrent
Ravindra Dhirubhai PatelManaging Director02 Jun 201610 Years 5 MonthsCurrent

Auditor

Omnibrx Biotechnologies Private Limited is audited by B S R and Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R and Co.FY 2023128510W

Shareholding

The shareholding of Omnibrx Biotechnologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Omnibrx Biotechnologies Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.13 Cr
Satisfied charges
None
Breakdown by lending institutions
Sidbi₹1.00 Cr
Hdfc Bank Limited₹0.13 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Aug 2021100486667Hdfc Bank Limited₹12.51 LakhOpen
16 Aug 2019100292600Sidbi₹1 CrOpen

Total charge records: 2 View all charges

Deals & funding

Omnibrx Biotechnologies Private Limited has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.

Total deals
7
Rights issues
4
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹30.99 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Mar 2023Funding round · Series A₹29.99 CrInvestors: SIDBI Ventures
Jul 2020Funding round · Seed₹99.9 LakhInvestors: Venture Center
Mar 2020Rights issue₹21 LakhInvestors: an individual
Nov 2018Rights issue₹68 LakhInvestors: 4 individuals
Sep 2017Rights issue₹46.8 LakhInvestors: 4 individuals

To see the full deal history of Omnibrx Biotechnologies Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Omnibrx Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Omnibrx Biotechnologies Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1
Employee growth
-36.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2723
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Omnibrx Biotechnologies Private Limited, buy the company report.

GST

Omnibrx Biotechnologies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AACCO3300N1ZOGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Omnibrx Biotechnologies Private Limited, buy the company report.

Recent activity

Omnibrx Biotechnologies Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Chintan Kaushik Gandhi ceased to be Nominee Director on 24 Jun 2025.

Ceased
Chintan Kaushik Gandhi ceased to be Nominee Director.
Ceased
Debraj Banerjee ceased to be Nominee Director.
AGM
Omnibrx Biotechnologies Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
Omnibrx Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Priti Dilip Rathi ceased to be Nominee Director.
Ceased
Ravindra Dhirubhai Patel ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.51 Lakh with Charge ID 100486667 was registered on 04 Aug 2021.
Charges
A charge with Sidbi amounted to Rs. 100.00 Lakh with Charge ID 100292600 was registered on 16 Aug 2019.
Appointed
Heenaben Ravindrakumar Patel was appointed as Director.
Ceased
Nilesh Karshanbhai Patel ceased to be Director.
Appointed
Ravindra Dhirubhai Patel was appointed as Managing Director.
Incorporation
02 Jun 2016
Omnibrx Biotechnologies Private Limited was registered on 02 Jun 2016 with Roc Ahmedabad & aged 10 years 5 months as per MCA records.

Frequently asked questions

Omnibrx Biotechnologies is an active private limited company based in Ahmedabad, Gujarat, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 02 June 2016 (10+ years old) and is registered under CIN U29306GJ2016PTC092297.

Omnibrx Biotechnologies has 2 current directors:

The latest financial statements of Omnibrx Biotechnologies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Omnibrx Biotechnologies is 24AACCO3300N1ZO, registered in Gujarat.

The CIN (Corporate Identification Number) of Omnibrx Biotechnologies is U29306GJ2016PTC092297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Omnibrx Biotechnologies was incorporated on 02 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Omnibrx Biotechnologies has 7 deals on record (4 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹30.99 Cr; the latest was in March 2023.

Chintan Kaushik Gandhi ceased to be Nominee Director on 24 Jun 2025. Debraj Banerjee ceased to be Nominee Director on 22 Nov 2024. Priti Dilip Rathi ceased to be Nominee Director on 30 Mar 2023. Omnibrx Biotechnologies has 7 board changes on record in total.

Yes, Omnibrx Biotechnologies is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0087940).

Omnibrx Biotechnologies can be reached through the website omnibrx.com. Its registered office is in Ahmedabad, Gujarat, India.